[Thrombolytic therapy in cerebrovascular disease].
Alvaro
L C
LC
Sección de Neurología, Hospital de Basurto, Bilbao.
Sádaba
F
F
D002545:Brain Ischemia / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000628:therapy; D010960:Plasminogen Activators / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator